2020
DOI: 10.7759/cureus.12174
|View full text |Cite
|
Sign up to set email alerts
|

A Rare Case of Parvovirus B19 Infection Manifesting as Chronic Aplastic Anemia and Neutropenia in a Human Immunodeficiency Virus-Infected Patient

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 7 publications
1
4
0
Order By: Relevance
“…The low Influenza A/H1N1 genome copy number in cardiac tissues associated with a significant PVB19 genome copy number supports the hypothesis of a reactivated PVB19-induced acute myocarditis during an Influenza A/H1N1 infection, as reported for other viruses associated with PVB19: CMV [ 26 ], HHV6 [ 27 ], EBV [ 28 ], HIV [ 29 ], and IAB [ 30 ]. However, PVB19 coinfection with Influenza A virus has not been reported.…”
Section: Discussionsupporting
confidence: 68%
“…The low Influenza A/H1N1 genome copy number in cardiac tissues associated with a significant PVB19 genome copy number supports the hypothesis of a reactivated PVB19-induced acute myocarditis during an Influenza A/H1N1 infection, as reported for other viruses associated with PVB19: CMV [ 26 ], HHV6 [ 27 ], EBV [ 28 ], HIV [ 29 ], and IAB [ 30 ]. However, PVB19 coinfection with Influenza A virus has not been reported.…”
Section: Discussionsupporting
confidence: 68%
“…There may be possibility of reactivation of Parvovirus B 19 during COVID-19 infection. Immunosuppression or modulation are known to be the main factors of PVB19 reactivation" [9,10].…”
Section: Discussionmentioning
confidence: 99%
“…The virus has the ability to stay within a cellular reservoir, resulting in relapsing and remitting bouts of a B19 infection [3,4,6,7]. This can be combated by the use of intravenous administration of IgG antibodies against the B19 viral capsid [5][6][7]. It is increasingly important for patients with HIV to be persistently monitored for persistent B19 infection.…”
Section: Discussionmentioning
confidence: 99%
“…An infection with B19 generally self-resolves with the production of specific antibodies that reduce viral action on erythroid progenitor cells by binding to the viral capsid [ 4 ]. As the adaptive immune system creates more IgM antibodies against B19, viremia declines and the subsequent destruction of erythroid progenitor cells declines accordingly [ 5 ]. B19-specific IgM and IgG antibodies are generally produced between two and three weeks, respectively, after primary B19 infection, and these antibodies are responsible for the elimination of B19 [ 6 ].…”
Section: Discussionmentioning
confidence: 99%